Home » Clinical laboratory » Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2 Acorda Therapeutics.

Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2 Acorda Therapeutics.

Collaborating under this C-TRIP grant will allow us to leverage our complementary skills toward a common objective of advancing the treatment of patients with center failure,’ stated Doug Sawyer, M.D., Ph.D., Lisa M. Jacobson Professor of Medication, Vanderbilt University Vascular and Cardiovascular Institute.. Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2 Acorda Therapeutics, Inc. today announced the National Center, Lung, and Bloodstream Institute provides awarded a $1 million Cardiac Translational Research Implementation Plan grant to aid research on Glial Growth Aspect 2 , a novel investigational agent for the treating patients with heart failing under development at Acorda.The nagging issues that cause alcoholism, and the nagging issues that alcohol causes, can cause a lifetime of damage. Find help, find support, and discover relief to be able to be free.. On the heels of CVS Health’s 1-yr anniversary of stopping tobacco sales, a viewpoint provides a detailed history of the long, cozy romantic relationship between drugstore chains and tobacco companies. While all leading drugstore chains have traditionally sold tobacco products, CVS has made many efforts to distance itself out of this practice, authors David Tuller, DrPH, and Lisa Bero, PhD, noted.